OTCMKTS:RCPIQ Rock Creek Pharmaceuticals (RCPIQ) Stock Price, News & Analysis → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free RCPIQ Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Rock Creek Pharmaceuticals alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Rock Creek Pharmaceuticals Stock (OTCMKTS:RCPIQ)Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> RCPIQ Stock News HeadlinesApril 18, 2024 | msn.comRock Creek Park Golf Course glow up set to begin later this yearApril 18, 2024 | finance.yahoo.comRock Creek Foundation Celebrates 50th Anniversary with Gala EventApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 17, 2024 | msn.comRock Creek Park Golf Course to undergo rehabilitationApril 17, 2024 | washingtonpost.comRock Creek Park Golf Course to undergo major, two-year renovationFebruary 29, 2024 | health.usnews.comIndependent Living Communities Near Rock Creek Park, COFebruary 5, 2024 | msn.com2024 Nissan Pathfinder Rock Creek Review: The Cost Of Driving ConfidenceFebruary 4, 2024 | msn.comDWR building dams along Red Rock Creek in hopes beavers will take them overApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 10, 2024 | msn.com'We're dangerous when rolling': Oklahoma Christian routs undefeated North Rock CreekDecember 13, 2023 | sports.yahoo.comGIRLS' BASKETBALL ROUNDUP: Rock Creek rolls over Christian AcademyDecember 9, 2023 | msn.comLight up the holidays with Miracle at Big Rock CreekDecember 1, 2023 | msn.comStudent proposals for Rock CreekNovember 13, 2023 | msn.comClasses canceled for Rock Creek Middle School as water issues persistNovember 8, 2023 | msn.comWoman hits Rock Creek firefighter, drives awayNovember 7, 2023 | msn.comRock Creek Firefighter injured while responding to two vehicle injury crashNovember 5, 2023 | msn.comAlcohol "believed to be a factor" in Saturday night's fatal crash on Rock Creek RoadNovember 3, 2023 | msn.comChasing Jesse James at Split Rock Creek and Devil's Gulch Parks in Garretson, SDNovember 2, 2023 | msn.comCritics blast plan to remove 1,200 trees from Rock Creek Park golf course - MSNOctober 27, 2023 | msn.comNational Park Service mulls removal of 1,200 trees from Rock Creek Park Golf CourseOctober 26, 2023 | msn.comRock Creek Park Golf Course restoration: DC's historic charm at the cost of 1,200 trees?October 25, 2023 | msn.comThe Nissan Pathfinder Rock Creek Edition was made for IdahoOctober 25, 2023 | msn.comWater main break closes lanes near Rock Creek Trail in Montgomery CountyOctober 22, 2023 | msn.comRezoning for homes near Naples Airport on Rock Creek heads to Collier County commissionersOctober 18, 2023 | forbes.comLittle Rock, AROctober 16, 2023 | news.yahoo.comRock Creek woman wins statewide Hospice awardOctober 13, 2023 | msn.comKPZ Pregame Week 7: Rock Creek vs. Clay CenterSee More Headlines Receive RCPIQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rock Creek Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:RCPIQ Previous SymbolNASDAQ:RCPI CUSIPN/A CIK776008 Webwww.rockcreekpharmaceuticals.com Phone(844) 727-0727Fax302-636-5454Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Michael John Mullan MBBS (M.D. (Age 65)), Ph.D., Chairman, Chief Exec. Officer and Pres Comp: $658.99kDr. Curtis Wright IV (Age 73)Sr. VP and Medical & Clinical Director Key CompetitorsDiamond WellnessOTCMKTS:POTNEntia BiosciencesOTCMKTS:ERGOJinhua Marine BiologicalOTCMKTS:JNMBPacificHealth LaboratoriesOTCMKTS:PHLISNDLNASDAQ:SNDLView All Competitors RCPIQ Stock Analysis - Frequently Asked Questions How do I buy shares of Rock Creek Pharmaceuticals? Shares of RCPIQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RCPIQ) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rock Creek Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.